Consistent with previous studies (24, 25, 31), these results confirmed that upregulation of TOMM34 expression was significantly associated with unfavorable prognosis in colon cancer and indicated that TOMM34 may serve as an oncogene by facilitating tumor progression and immunosuppression. Here, TOMM34 is linked to colonic neoplasm.